ReviewInternational journal of preventive medicine2023

The Prevalence of Cancer in Patients with Multiple Sclerosis (MS) who were Under Treatment with Natalizumab (Tysabri): A Systematic Review and Meta-Analysis.

Amirreza Nasirzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.